Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1
Brianna M. Brooks(National Center for Advancing Translational Sciences), Wei Zheng(Liaoning Cancer Hospital & Institute), Manisha Pradhan(National Institutes of Health), Atena Farkhondeh(National Institutes of Health), Kirill Gorshkov(National Center for Advancing Translational Sciences), Steven Rodems(Northrop Grumman (United States)), Chengyu Liu(National Institutes of Health), Jeanette Beers(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Yu‐Shan Cheng(National Institutes of Health), Karsten Baumgaertel(Therapeutics Clinical Research)
Cited by 4
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Modulation of β-Amyloid Precursor Protein Processing by the Low Density Lipoprotein Receptor-related Protein (LRP)
|Journal of Biological Chemistry|2000|263
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225